Trial reportScientific reports2026
Premixed nitrous oxide/oxygen analgesia for removal of vacuum assisted closure dressing: a randomized, double-blinded placebo-controlled trial.
Trial report in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Vacuum assisted closure (VAC) is commonly used in clinical practice to promote wound healing. During the dressing removal of VAC, patients may suffer from different degrees of pain, or even discontinue treatment due to severe pain. Our study sought to determine whether or not nitrous oxide analgesia decreases pain compared to oxygen placebo during removal of VAC dressing. This study is a double-blind, placebo-controlled randomized trial targeting patients who underwent replacement of VAC dressings in orthopedics. All patients were randomized in a 1:1 ratio to receive 65% premixed nitrous oxide/oxygen versus 100% oxygen. The primary outcome was the intensity of pain during the intervention. Secondary outcomes included adverse effects, satisfaction of patients, and physiological parameters (blood pressure, heart rate, oxygen saturation). Between 18 February, 2022 and 9 May, 2023, 114 participants were enrolled, 57 patients were allocated to the intervention group (premixed nitrous oxide/oxygen), 57 patients were enrolled in the control group (oxygen). The baseline and procedural characteristics were comparable between the two groups. The pain score reported by patients immediately after removing the dressing in the intervention group was significantly lower than that in the control group (median 3.0 vs. 6.3, P < 0.001). The satisfaction of patients in the intervention group significantly increased (Z=-6.861, P < 0.001). There were no significant differences in vital signs, operation duration, and adverse reactions between the two groups. Premixed nitrous oxide/oxygen can reduce the pain caused by removal VAC dressing in patients and can be considered an effective analgesic measure.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.